|
PG
|
Consumer Defensive |
Morgan StanleyB |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$346.8B
|
$96.49
|
-0.0%
|
+0.2%
|
-4.0%
|
-0.3%
|
-0.8%
|
-0.8%
|
|
NVO
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$197.0B
|
$23.39
|
-0.8%
|
-0.6%
|
-0.6%
|
-1.9%
|
-1.0%
|
+1.1%
|
|
ADBE
|
Technology |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$108.2B
|
$248.08
|
-3.0%
|
-7.3%
|
-3.7%
|
+2.2%
|
-0.7%
|
-2.7%
|
|
GSK
|
Healthcare |
Morgan Stanley |
Maintains
|
Underweight
→
Underweight
|
—
|
$105.1B
|
$37.94
|
-0.9%
|
-0.9%
|
-1.4%
|
+0.1%
|
+0.8%
|
+1.3%
|
|
AMRX
|
Healthcare |
Morgan Stanley |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$4.0B
|
$16.33
|
-7.8%
|
-1.3%
|
+0.6%
|
-1.9%
|
-5.8%
|
-5.6%
|
|
SIMO
|
Technology |
Morgan Stanley |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$2.1B
|
$34.43
|
-4.4%
|
-3.6%
|
+0.1%
|
+1.0%
|
-0.7%
|
-1.6%
|